Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The Leukemia Research Foundation announces 2024-2026 research grant recipients


News provided by

Leukemia Research Foundation

Aug 13, 2024, 13:55 ET

Share this article

Share toX

Share this article

Share toX


The Leukemia Research Foundation announces the recipients of the 2024-2026 New Investigator Research Grant Program. Grants of $150K, over a two-year period, have been awarded to nine new investigators worldwide.

NORTHFIELD, Ill., Aug. 13, 2024 /PRNewswire-PRWeb/ -- The Leukemia Research Foundation is pleased to announce the recipients of the 2024-2026 New Investigator Research Grant Program. Grants of $150K, over a two-year period, have been awarded to nine new investigators worldwide.

This total investment of $1.35M is in addition to currently funded leukemia research for the 2023-2025 period, as well as the hundreds of other previously funded cutting-edge projects. Overall, the Leukemia Research Foundation has funded more than 600 projects since its inception.

"They are some of the best and brightest young scientists in the field, selected from a highly competitive pool of applicants." ~ Kevin Radelet, executive director Leukemia Research Foundation

Post this

"We are excited about the fresh, new ideas and perspectives these investigators bring to leukemia research," said Kevin Radelet, executive director. "They are some of the best and brightest young scientists in the field, selected from a highly competitive pool of applicants. Research is the center of our mission, and by funding groundbreaking projects across all types of leukemia, new treatments are being pioneered. As those discoveries happen, each one is moving us closer to a cure."

Innovative projects

The Leukemia Research Foundation's competitive, peer-reviewed program funds innovative projects from early-career investigators who propose research that can lead to scientific breakthroughs.

This year's research projects span a range of topics to advance discoveries in:

  • Cancer cell biology, including T cell leukemias
  • Treatments, including immunotherapies
  • Causes and risk factors, including those of myelodysplastic syndrome (MDS), Richter transformation, and genetically based therapy resistance

The New Investigator Research Grant recipients for 2024-2026 are included below, and specific details about their background and projects can be found on our website.

  • Shruti Bhatt, PhD, Assistant Professor - Emory University
  • Franco Izzo, PhD, Assistant Professor - Icahn School of Medicine at Mount Sinai
  • Nadia Kershaw, D. Phil., Laboratory Head - Walter and Eliza Hall Institute of Medical Research - Victoria, Australia
  • Shan Lin, PhD, Principal Investigator - Seattle Children's Hospital
  • Ioanna Mosialou, PhD, Assistant Professor - Columbia University Medical Center
  • Santhosh K. Pasupuleti, PhD, Assistant Research Professor - Indiana University
  • Elisa ten Hacken, PhD, Assistant Professor - Weill Medical College of Cornell University
  • Alejandro Villarino, PhD, Assistant Professor - Sylvester Comprehensive Cancer Center/University of Miami Health Systems
  • Eric Wang, PhD, Assistant Professor - The Jackson Laboratory for Genomic Medicine

Peer-reviewed process

The Foundation is grateful to the 24 physician-scientists and researchers from prominent medical institutions around the world who participated in this year's grant review. The panel evaluated the proposals using similar methodology to that used by the National Institutes of Health (NIH). Led by Justin Kline, MD, professor of medicine, University of Chicago Medicine, the review process culminated in the recommendation of nine projects for funding.

To learn more about the Leukemia Research Foundation's New Investigator Research Grant Program and the deadlines for the 2025 grant program, visit leukemiarf.org/research.

About the Leukemia Research Foundation

The Leukemia Research Foundation, headquartered in Northfield, Illinois, is committed to funding innovative leukemia research worldwide and supporting people affected by leukemia. Since its founding in 1946, more than $90M has been raised to pursue better treatments and the ultimate cure for leukemia. As the nation's largest nonprofit focused exclusively on funding leukemia research, the Leukemia Research Foundation has invested millions in more than 600 research projects worldwide to accelerate the development of new and better treatments.

Media Contact

Maureen Jones, Leukemia Research Foundation, 1 847.919.6250, [email protected], leukemiarf.org

Twitter

SOURCE Leukemia Research Foundation

Modal title

Nine new investigators from around the world have been awarded the Leukemia Research Foundation's 2024-2026 New Investigator Research Grant.
Nine new investigators from around the world have been awarded the Leukemia Research Foundation's 2024-2026 New Investigator Research Grant.
The Leukemia Research Foundation is the nation's largest nonprofit focused exclusively on funding leukemia research.
The Leukemia Research Foundation is the nation's largest nonprofit focused exclusively on funding leukemia research.
Nine new investigators from around the world have been awarded the Leukemia Research Foundation's 2024-2026 New Investigator Research Grant. The Leukemia Research Foundation is the nation's largest nonprofit focused exclusively on funding leukemia research.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.